模拟基质进入血脑屏障的P-糖蛋白流量
Christian Jorgensen1, Martin B Ulmschneider2, Peter C Searson1,3
1Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Journal of medicinal chemistry
|December 14, 2023
概括
分子动力学模拟揭示了罗达胺如何进入P-gp.
科学领域:
- 生物物理学的生物物理.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- P-glycoprotein (P-gp) 是一个关键的排泄,与多药性耐药性有关.
- 了解基质进入P-gp对于开发有效的抑制剂至关重要.
- 罗达胺作为研究P-gp运输机制的模型基质.
研究的目的:
- 研究罗达胺进入P-gp结合腔的分子机制.
- 确定控制基质转移的结构因素.
- 为了阐明P-gp抑制的机制通过tariquidar.
主要方法:
- 用分子动力学 (MD) 模拟来建模罗达胺-P-gp相互作用.
- 模拟集中在P-gp的向内开放形状上.
- 进行了基质扩散和中央腔内结合的分析.
主要成果:
- 罗达胺通过被动运输或横向扩散进入P-gp内部体积.
- 在蛋白质顶部的27°临界开口角控制了入口.
- 减少移动性和较弱的结合在腔内限制罗达胺,促进排泄.
- 在P-gp下臂的塔里基达聚合物,表明进入或ATP接入的硬质障碍.
结论:
- P-gp光圈角是罗达胺进入的关键决定因素.
- P-gp结合腔的环境限制了罗达胺,使得效率高的排泄.
- 塔里基达尔的抑制作用可能涉及固体阻碍,影响基质进入和/或ATP结合.
相关概念视频
Carrier-Mediated Transport
441
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
441
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
41
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
41
Physiological Barriers
3.6K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.6K
The Blood-brain Barrier
47.4K
Overview
47.4K
Factors Affecting Drug Distribution: Physiological Barriers
208
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
208


